PSYC
+ Nucleus Form New Partnership to Develop and Launch Psychedelic
Finder
LAS VEGAS, NV --
September 15, 2022 -- InvestorsHub NewsWire -- PSYC
Corporation (OTCPink:
PSYC) ("PSYC" or the "Company"), a media leader focused on the
emerging psychedelic sector through its flagship platforms,
Psychedelic Spotlight and
Mushroom Stocks, is pleased to
announce that the Company has joined forces with
Nucleus Holding Inc., a venture studio
building psychedelic brands, to launch
Psychedelic Finder, a full-service,
integrated technology platform that will connect the growing
community of psychedelics and psychedelic-inspired
healing.
The partnership will be
facilitated through the execution of a Limited Liability Operating
Agreement between the companies on September 2, 2022. PSYC Tech,
LLC, a newly incorporated Nevada company will be owned and operated
jointly by the companies for the primary purpose of developing,
launching, and managing Psychedelic Finder. Furthermore, the
companies agreed to an initial 60/40 ownership structure whereby
PSYC is the majority member of the LLC.
Plans are to combine
the expansive audience and consistent month-over-month web traffic
produced by Psychedelic Spotlight and the domain,
www.psychedelicfinder.com, which the Company
acquired in 2020, with
Neuly, a data-driven
platform operated by Nucleus Holding Inc. The goal of the
partnership is the development and launch of a one-of-a-kind
platform to inspire the growing community of psychedelics to
explore, educate, connect, and even schedule bookings with an
expanding list of clinics, therapists, coaches, and retreats across
the globe.
"Competition, in my
opinion, is such an integral part of almost every industry's
development," said PSYC CEO, David Flores. "In many cases it's the
catalyst behind brands and companies producing superior products
and services for consumers in the spirit of open market competition
yielding best outcomes for both product quality and pricing
efficiency. Psychedelic Finder will not be the first online
directory for the psychedelic sector. However, we formed this
partnership with Nucleus because we see a unique opportunity to
leverage the resources on our end with Neuly's resources to develop
a platform that will go far beyond the simple utility of an online
directory. We're also building a community through social
engagement within an ecosystem. To meet those goals, we are excited
to collaborate with Nucleus in creating this new technology and
brand loyalty. Our collective goals are for Psychedelic Finder to
be every bit as socially engaging as it is resourceful, valuable,
and inspiring to the evolving community and marketplace focused on
the psychedelic lifestyle and healthcare."
Nucleus CEO, Logan Lenz
added, "I couldn't be more excited to partner with PSYC to
establish the Psychedelic Finder brand and help more people find
psychedelic medicines, treatments, and experiences around the
world. Our mission at Nucleus is to connect people with this
growing industry and movement, and I couldn't think of a better
partner in PSYC to help us reach a wider audience so we can
continue to power the well-being of millions of people over
time."
Over the coming weeks,
the companies plan to work meticulously on the backend development
of Psychedelic Finder with the intent of having a public launch in
the next 30-60 days.
PSYC CFO Craig
Schlesinger concluded with, "Developing the Psychedelic Finder
brand and technology represents a significant opportunity for PSYC
Tech to design the foundational architecture of a monetizable,
scalable asset for the psychedelic space writ large. Moreover, it's
another strategic low-cost, low-risk, high-reward maneuver to build
growth and value for PSYC shareholders."
Furthermore, the
Companies would like to reiterate that the core functionality of
Psychedelic Finder will be to connect consumers and patients with
licensed clinics, therapists, coaches, and retreats offering safe,
responsible, and legal services to the public. Psychedelic Finder
will not, in any way, facilitate, nor tolerate the facilitation of
sale of any illegal drugs or substances within, or through the use
of its platform.
About PSYC Corporation
(OTCPink:
PSYC)
At PSYC Corporation we
are integrating media, creativity, and technology to develop and
deploy thought-provoking ideas and solutions that are fostering and
transforming the approach to some of society's most pressing
matters.
PSYC has expressed its
intent and commitment to positioning itself at the forefront of the
psychedelic revolution and as a resource center for discovering and
understanding the latest research and business opportunities
surrounding psychedelic inspired medicines. In conjunction with the
FDA's more open-minded approach to psychedelic medicines, and as
several major U.S. cities continue to approve the decriminalization
of psilocybin, we believe investors are speculating that the
psychedelic boom could be bigger than that of cannabis. PSYC is
your source for current investment related news specific to
psychedelic medicines and cutting-edge research improving overall
health, moving this sector into the mainstream.
We are dedicated to a
forward-thinking approach that embraces groundbreaking new
technology and innovations and through the vision of business
development we intend to continue to evolve into these unchartered
territories as the industry leaders of the future.
About Spotlight Media
Corporation
Spotlight Media
Corporation ("SMC") (www.spotlightmediacorp.com) is a Nevada
Corporation and is a privately held wholly owned subsidiary of PSYC
that was incorporated on February 8, 2022. At present time, SMC
operates as a multimedia service company for the medicinal
psychedelic industry through Psychedelic Spotlight in addition to
the developing community-based platform, Bonfire (f/k/a
"PsycheDev"). However, management intends, but cannot guarantee the
success or profitability, that the business plan for SMC is to potentially expand
beyond the medicinal psychedelic industry by way of other
multimedia-related opportunities within other niche-style
industries like cannabis, health and wellness, and sports such
that
SMC can make use of the
audience it is establishing, across its
platforms for cross-promotional opportunities and with the intent
of developing a network of interconnected media-focused
platforms.
Forward-Looking
Statements Disclaimer:
This press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. In some cases, you
can identify forward-looking statements by the following words:
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "ongoing," "plan," "potential," "predict,"
"project," "should," "will," "would," or the negative of these
terms or other comparable terminology, although not all
forward-looking statements contain these words. Forward-looking
statements are not a guarantee of future performance or results and
will not necessarily be accurate indications of the times at, or
by, which such performance or results will be achieved.
Forward-looking statements are based on information available at
the time the statements are made and involve known and unknown
risks, uncertainty and other factors, including the effect of
COVID-19 and the success of the current vaccine distribution, the
adverse effect of the Omicron variant, that may cause our results,
levels of activity, performance or achievements to be materially
different from the information expressed or implied by the
forward-looking statements in this press release. This press
release should be considered in light of all filings of the Company
that are disclosed on the OTC Markets.com website and is not
incorporated by reference into such reports.
Disclaimer: PSYC
Corporation does not in any way encourage or condone the use,
purchase, sale or transfer of any illegal substances, nor do we
encourage or condone partaking in any unlawful activities. We
support a harm reduction approach for the purpose of education and
promoting individual and public safety. If you are choosing to use
psychedelic substances, please do so responsibly.
Corporate
Contact:
PSYC Corporation
(PSYC)
www.psyccorporation.com
www.spotlightmediacorp.com
(702) 330-0363
info@psyccorporation.com
OTCPINK: PSYC